CrushSCI.com
Journal Selection & Manuscript Polishing Services
CANCER GENE THERAPY journal cover Medicine
Back to journal directory

Review Cycle Records

CANCER GENE THERAPY

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q1
237.3Average days
232Median days
102Fastest days
408Longest days
1302025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

255 days

NCBP1 promotes the malignant progression of Wilms’ tumor through stabilization of KPNA2 mRNA

AuthorsYintao Cheng; Wu Wang; Jun Wang; Wei Lei; Yawei Zhang; Hui Guo; Fei Peng; Hang Liu

Affiliations1. Department of Urology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. Department of General Surgery, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Source PDF DOI Publisher page
247 days

The Tumor-suppressive role of CNTNAP2 in glioma: Dual regulation of the NDN-ERK axis and M2 macrophage polarization

AuthorsYu Wu; Weiwei Zou; Shiqi Xia; Ti Zhang; Fan Yao; Yangqin Li; Xiaoqian Liu; Qian Peng; Xiao-Liang Xing

Affiliations1. Department of Clinical Laboratory, Hunan University of Medicine General Hospital, Clinical School of Hunan University of Medicine, Hunan University of Medicine, Huaihua, China; 2. School of Public Health and Emergency Management, School of Medical Laboratory Science, Hunan University of Medicine, Huaihua, China; 3. Gynecological Oncology Department, Huaihua Central Hospital, Huaihua, China; 4. Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China

Source PDF DOI Publisher page
300 days

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion

AuthorsDebina Sarkar; Gaurav C. Gyanwali; Jaishree Patel; Polina Shevchuk; Aaron Jeffs; Adele G. Woolley; Selena Wang; Maryam Sardari; Apeksha Bhandarkar; Halima Siddiqui; Magdalena Ratajska; Makhdoom Sarwar; Srinivasaraghavan Kannan; Chandra S. Verma; Catherine J. Drummond; Cushla McKinney; Jisha Antony; Sally P. McCormick; Antony Braithwaite; Sunali Mehta

Affiliations1. Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand; 2. Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand; 3. Department of Biochemistry, University of Otago, Dunedin, New Zealand; 4. Division of Pathology and Neuropathology, Medical University of Gdansk, Gdansk, Poland; 5. Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand; 6. Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore; 7. Department of Biological Sciences, National University of Singapore, Singapore, Singapore; 8. School of Biological Sciences, Nanyang Technological University, Singapore, Singapore

Source PDF DOI Publisher page
102 days

The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR

AuthorsMamdouh A. Ragab; Nevine Fathy; Yasmin M. Attia; Eman A. Amer; Sally A. Fahim

Affiliations1. Biochemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt; 2. Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 3. Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt; 4. Department of Biochemistry, School of Pharmacy, Newgiza University (NGU), Giza, Egypt

Source PDF DOI Publisher page
217 days

GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity

AuthorsYiran Li; Yuting Shen; Wen Lu

Affiliations1. Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.